These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26587696)

  • 1. Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers.
    Tierney M; Finnell DS; Naegle MA; LaBelle C; Gordon AJ
    Subst Abus; 2015; 36(4):389-92. PubMed ID: 26587696
    [No Abstract]   [Full Text] [Related]  

  • 2. The prescribing of buprenorphine by advanced practice addictions nurses.
    Strobbe S; Hobbins D
    J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding access to nurse-managed medication for opioid use disorder.
    Cos TA; Starbird LE; Lee H; Chun B; Gonnella K; Bird J; Livsey K; Bastos S; O'Brien M; Clark I; Jenkins D; Tavolaro-Ryley L
    Nurs Outlook; 2021; 69(5):848-855. PubMed ID: 33992445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded buprenorphine prescribing privileges: Sandbagging in the midst of the flood?
    Brown JD; Nolte JL
    Res Social Adm Pharm; 2018 Jun; 14(6):617-618. PubMed ID: 29525482
    [No Abstract]   [Full Text] [Related]  

  • 5. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 6. Buprenorphine prescribing practice trends and attitudes among New York providers.
    Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
    J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021.
    Thakrar AP; Alexander GC; Saloner B
    JAMA Netw Open; 2021 Dec; 4(12):e2138807. PubMed ID: 34905010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical specialty of buprenorphine prescribers for pregnant women with opioid use disorder.
    Hollander MAG; Jarlenski MP; Donohue JM; Cole ES; Kelley D; Krans EE
    Am J Obstet Gynecol; 2019 May; 220(5):502-503. PubMed ID: 30703340
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescribing patterns of buprenorphine waivered physicians.
    Thomas CP; Doyle E; Kreiner PW; Jones CM; Dubenitz J; Horan A; Stein BD
    Drug Alcohol Depend; 2017 Dec; 181():213-218. PubMed ID: 29096292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Different Buprenorphine Treatment Settings With Similar Retention Rates: Implications for Expanding Access to Treatment for Opioid Use Disorder.
    Tierney M; Melino K; Adeniji A; Shumway M; Allen IE; Waters CM
    J Am Psychiatr Nurses Assoc; 2019; 25(4):305-313. PubMed ID: 30295107
    [No Abstract]   [Full Text] [Related]  

  • 11. Access to treatment for opioid use disorders: Medical student preparation.
    McCance-Katz EF; George P; Scott NA; Dollase R; Tunkel AR; McDonald J
    Am J Addict; 2017 Jun; 26(4):316-318. PubMed ID: 28394437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
    Trigg BG; Dickman SL
    Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling the Swing of the Opioid Pendulum.
    Comerci G; Katzman J; Duhigg D
    N Engl J Med; 2018 Feb; 378(8):691-693. PubMed ID: 29466151
    [No Abstract]   [Full Text] [Related]  

  • 14. Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact.
    Miele GM; Caton L; Freese TE; McGovern M; Darfler K; Antonini VP; Perez M; Rawson R
    J Subst Abuse Treat; 2020 Jan; 108():20-25. PubMed ID: 31399272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving access to care through Advanced Practice Registered Nurses: Focus on perinatal patients with Opioid Use Disorder.
    Ramage M; Tak C; Goodman D; Johnson E; Barber C; Jones HE
    J Adv Nurs; 2021 Jan; 77(1):4-10. PubMed ID: 32975850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Community Partnership to Improve Access to Buprenorphine in a Homeless Population.
    Leo P; Gastala N; Fleurimont J; Messmer S; Maes P; Richardson J; Neeb C; Stackhouse N; Koruba S; Watson DP
    Ann Fam Med; 2021; 19(1):85. PubMed ID: 33431401
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of buprenorphine treatment for opioid dependence.
    Murphy SM; Fishman PA; McPherson S; Dyck DG; Roll JR
    J Subst Abuse Treat; 2014 Mar; 46(3):315-9. PubMed ID: 24209382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pain in patients taking buprenorphine for opioid addiction #221.
    Childers JW; Arnold RM
    J Palliat Med; 2012 May; 15(5):613-4. PubMed ID: 22577788
    [No Abstract]   [Full Text] [Related]  

  • 19. Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions.
    Spetz J; Toretsky C; Chapman S; Phoenix B; Tierney M
    JAMA; 2019 Apr; 321(14):1407-1408. PubMed ID: 30964519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
    Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.